Univariate analysis demonstrated an association of higher eNOS expression with progression/metastatic disease (Table 2 and Figure 2C), in agreement with previous data on surgical tissue [23] and straightening the relevance of these results, since analysis on prostatic biopsy in some cases presents limitations and often does not confirm data obtained from tissue [44]. The gene discussed is NOS3; the disease is metastatic neoplasm.